How clinicians can detect, prevent and treat medication overuse headache

Cephalalgia

Volumn 28, Issue 11, 2008, Pages 1207-1217

  Dodick, D W ^a   Silberstein, S D ^b  

^a MAYO CLINIC   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROERGOTAMINE; ERGOTAMINE TARTRATE; NONSTEROID ANTIINFLAMMATORY AGENT; TOPIRAMATE;

ANALGESIC AGENT ABUSE; ANXIETY; CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DISEASE CLASSIFICATION; DRUG DETOXIFICATION; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG USE; HEADACHE; HUMAN; MIGRAINE; PRACTICE GUIDELINE; REVIEW; SUBSTANCE ABUSE; PHYSICIAN; SECONDARY HEADACHE;

CLINICAL TRIALS AS TOPIC; HEADACHE DISORDERS, SECONDARY; HUMANS; PHYSICIANS;

EID: 53549110757     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01737.x     Document Type: Review

References (76)

1. Headache Classification Committee of the International Headache Society. The international classification of headache disorders (second edition). Cephalalgia 2004 24 (Suppl 1 1 160.
2. Mathew NT, Kurman R, Perez F. Drug induced refractory headache-clinical features and management. Headache 1990 30 : 634 8.
3. Zwart JA, Dyb G, Hagen K, Svebak S, Stovner LJ, Holmen J. Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology 2004 62 : 1540 4.
4. Colas R, Munoz P, Temprano R, Gomez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004 62 : 1338 42.
5. Dyb G, Holmen TL, Zwart JA. Analgesic overuse among adolescents with headache: the Head-HUNT-Youth Study. Neurology 2006 66 : 198 201.
6. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999 39 : 190 6.
7. Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 2001 21 : 980 6.
8. Chakravarty A. Chronic daily headaches: clinical profile in Indian patients. Cephalalgia 2003 23 : 348 53.
9. Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 2006 46 : 766 72.
10. Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache 1987 27 : 102 6.
11. Rapoport A, Stang P, Gutterman DL, Cady R, Markley H, Weeks R et al. Analgesic rebound headache in clinical practice: data from a physician survey. Headache 1996 36 : 14 9.
12. Tepper SJ. Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is a cause of chronic daily headache. Headache 2002 42 : 543 7.
13. Dodick DW. Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is not a cause of chronic daily headache. Headache 2002 42 : 547 54.
14. Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006 66 : 1894 8.
15. Wilkinson SM, Becker WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 2001 41 : 303 9.
16. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003 43 : 179 90.
17. Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004 62 : 788 90.
18. D'Amico D, Grazzi L, Usai S, Rigamonti A, Curone M, Bussone G. Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura. Headache 2005 45 : 553 60.
19. Grazzi L, Andrasik F, D'Amico D, Usai S, Kass S, Bussone G. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up. Headache 2004 44 : 678 83.
20. Lafittau M, Radat F, Irachabal S, Creac'h C. Headache and transformed migraine with medication overuse: what differences between disability, emotional distress and coping? Encephale 2006 32 : 231 7.
21. Silvestrini M, Bartolini M, Coccia M, Baruffaldi R, Taffi R, Provinciali L. Topiramate in the treatment of chronic migraine. Cephalalgia 2003 23 : 820 4.
22. Mei D, Ferraro D, Zelano G, Capuano A, Vollono C, Gabriele C, Di Trapani G. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Clin Neuropharmacol 2006 29 : 269 75.
23. Dodick DW, Bigal M, Silberstein SD, Mathew NT, Hulihan J, Ascher S et al. Efficacy of topiramate treatment for chronic migraine in patients with medication overuse. Headache 2007 47 : 761.
24. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ. TOPMAT-MIG-201 (TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007 27 : 814 23.
25. Landy SH, Baker JD. Divalproex ER prophylaxis in migraineurs with probable chronic migraine and probable medication-overuse headache: a case series. Pain Pract 2004 4 : 292 4.
26. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006 26 : 742 6.
27. Dodick D, Freitag F. Evidence-based understanding of medication-overuse headache: clinical implications. Headache 2006 46 (Suppl 4 S202 11.
28. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002 59 : 1011 14.
29. Radat F, Creac'h C, Swendsen JD, Lafittau M, Irachabal S, Dousset V, Henry P. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 2005 25 : 519 22.
30. Blau JN. Fears aroused in patients by migraine. BMJ (Clin Res Ed) 1984 288 : 1126.
31. Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M et al. The International Classification of Headache Disorders, 2nd Edition (ICHD-II) - revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 2005 25 : 460 5.
32. Saper JR, Hamel RL, Lake AE, 3rd. Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia 2005 25 : 545 6.
33. Lake AE, 3rd. Medication overuse headache: biobehavioral issues and solutions. Headache 2006 46 (Suppl 3 S88 97.
34. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004 3 : 475 83.
35. Silberstein SD, Frietag F, Dodick DW, Argoff C, Pearlman SH. Practice parameter: preventive treatment of migraine in adults. Report of the quality standards subcommittee of the American Academy of Neurology. Neurology in press.
36. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007 68 : 343 9.
37. Limmroth V, Biondi D, Pfeil J, Schwalen S. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache. Headache 2007 47 : 13 21.
38. Paemeleire K, Crevits L, Goadsby PJ, Kaube H. Practical management of medication-overuse headache. Acta Neurol Belg 2006 106 : 43 51.
39. Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet 1991 337 : 1442 3.
40. Katsarava Z, Jensen R. Medication-overuse headache: where are we now? Curr Opin Neurol 2007 20 : 326 30.
41. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001 57 : 1694 8.
42. Warner JS. Prolonged recovery from rebound headaches. Headache 2001 41 : 817 22.
43. Relja G, Granato A, Bratina A, Antonello RM, Zorzon M. Outcome of medication overuse headache after abrupt in-patient withdrawal. Cephalalgia 2006 26 : 589 95.
44. Andrasik F. Behavioral treatment approaches to chronic headache. Neurol Sci 2003 24 (Suppl 2 S80 5.
45. Silberstein SD, Schulman EA, Hopkins MM. Repetitive intravenous DHE in the treatment of refractory headache. Headache 1990 30 : 334 9.
46. Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986 36 : 995 7.
47. Krymchantowski AV, Moreira PF. Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia 2003 23 : 982 93.
48. Evans RW, Young WB. Droperidol and other neuroleptics/antiemetics for the management of migraine. Headache 2003 43 : 811 3.
49. Mathew NT. Amelioration of ergotamine withdrawal symptoms with naproxen. Headache 1987 27 : 130 3.
50. Schwartz TH, Karpitskiy VV, Sohn RS. Intravenous valproate sodium in the treatment of daily headache. Headache 2002 42 : 519 22.
51. Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006 26 : 1097 105.
52. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes. Cephalalgia 2004 24 : 483 90.
53. Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 2003 60 : 1682 3.
54. Diener HC, Dichgans J, Scholz E, Geiselhart S, Gerber WD, Bille A. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 1989 236 : 9 14.
55. Schnider P, Aull S, Baumgartner C, Marterer A, Wöber C, Zeiler K, Wessely P. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia 1996 16 : 481 5.
56. Baumgartner C, Wessely P, Bingol C, Maly J, Holzner F. Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989 29 : 510 14.
57. Fritsche G, Diener HC. Medication overuse headaches - what is new? Exp Opin Drug Saf 2002 1 : 331 8.
58. Fritsche G, Eberl A, Katsarava Z, Limmroth V, Diener HC. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 2001 45 : 229 35.
59. Pini LA, Cicero AF, Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 2001 21 : 878 83.
60. Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005 25 : 12 5.
61. Tribl GG, Schnider P, Wober C, Aull S, Auterith A, Zeiler K, Wessely P. Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia 2001 21 : 691 6.
62. Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 1999 19 : 44 9.
63. Young WB. Medication overuse headache. Curr Treat Options Neurol 2001 3 : 181 8.
64. Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache 2006 46 : 1334 43.
65. Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004 61 : 490 5.
66. Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004 291 : 965 73.
67. Diener HC, Tfelt-Hansen P, Dahlof C, Láinez MJ, Sandrini G, Wang SJ et al. Topiramate in migraine prophylaxis - results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004 251 : 943 50.
68. Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007 47 : 170 80.
69. Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S et al. Migraine prophylaxis with divalproex. Arch Neurol 1995 52 : 281 6.
70. Klapper J. Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 1997 17 : 103 8.
71. Silberstein SD, Collins SD. Long-term Safety of Depakote in Headache Prophylaxis Study Group. Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Headache 1999 39 : 633 43.
72. Depakote ER. (divalproex sodium extended-release tablets) prescribing information. Abbott Laboratories, North Chicago, Illinois; October 2006.
73. Freitag FG, Diamond S, Diamond ML, Urban GJ. Divalproex in the long-term treatment of chronic daily headache. Headache 2001 41 : 271 8.
74. Lake AE, 3rd. Behavioral and nonpharmacologic treatments of headache. Med Clin North Am 2001 85 : 1055 75.
75. Blanchard EB, Taylor AE, Dentinger MP. Preliminary results from the self-regulatory treatment of high-medication-consumption headache. Biofeedback Self Regul 1992 17 : 179 202.
76. Grazzi L, Andrasik F, D'Amico D, Leone M, Usai S, Kass SJ, Bussone G. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 2002 42 : 483 90.